205 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Protozoan Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cryptosporidiosis and Enteropathogens in Bangladesh
Condition: Cryptosporidiosis
Intervention:
2 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
5 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
6 Unknown  Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
8 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
9 Not yet recruiting MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
Condition: Malaria
Intervention: Drug: MMV390048
10 Not yet recruiting RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission
Condition: Malaria
Intervention: Biological: dihydroartemisinin-piperaquine
11 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
12 Recruiting SJ733 Induced Blood Stage Malaria Challenge Study
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: (+)-SJ000557733
13 Not yet recruiting Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Conditions: Toxoplasmosis Infection;   Genotype II;   Ocular Toxoplasmosis With Recurrences
Intervention: Biological: seropositive for Toxoplasma gondii
14 Not yet recruiting Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition: Malaria
Interventions: Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (for CHMI);   Other: Normal Saline;   Biological: PfSPZ Challenge (for PfSPZ-CVac)
15 Not yet recruiting Methylene Blue Against Falciparum Malaria in Burkina Faso
Condition: Malaria, Falciparum
Interventions: Drug: Methylene Blue;   Drug: Primaquine
16 Recruiting Asymptomatic Leishmania Infection in HIV Patients
Condition: Visceral Leishmaniasis
Intervention:
17 Recruiting Controlled Human Malaria Infection Model for Evaluation of Transmission‐Blocking Interventions - Study 1
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine (low dose);   Drug: Piperaquine (low dose);   Drug: Sulfadoxine-pyrimethamine (high dose);   Drug: Piperaquine (high dose);   Biological: malaria challenge infection, P. falciparum 3D7;   Drug: Atovaquone-proguanil
18 Not yet recruiting Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Matched-Placebo for Tafenoquine;   Drug: Primaquine;   Drug: Matched-Placebo for Primaquine;   Drug: Dihydroartemisinin-piperaquine (DHA-PQP);   Drug: ACT plus PQ (Rescue medication);   Drug: PQ (End of study treatment)
19 Not yet recruiting Child Follow-up Until 2 Years
Conditions: Malaria;   Pregnancy
Intervention:
20 Not yet recruiting Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
Condition: Malaria
Interventions: Drug: Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy;   Drug: Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years